Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
UBS
Cantor Fitzgerald
Cerilliant
Teva
Moodys
Daiichi Sankyo
US Department of Justice
Healthtrust

Generated: December 16, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Phenergan

« Back to Dashboard

Bulk Pharmaceutical API Sources for Phenergan

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ➤ Sign Up P4651_SIGMA ➤ Sign Up
NovoSeek ➤ Sign Up 6014 ➤ Sign Up
MolPort ➤ Sign Up MolPort-003-666-272 ➤ Sign Up
Hangzhou APIChem Technology ➤ Sign Up AC-12482 ➤ Sign Up
NIH Clinical Collection ➤ Sign Up SAM002264636 ➤ Sign Up
ABI Chem ➤ Sign Up AC1L1LM3 ➤ Sign Up
ChemMol ➤ Sign Up 30102237 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
McKesson
Chubb
Chinese Patent Office
UBS
Johnson and Johnson
Fish and Richardson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.